Brief: Aker BioMarine Q4 Revenue Misses Analyst Expectations
15/02/2023 06:12
Feb 15 (Reuters) - Aker BioMarine Q4 revenue USD 79 million vs. estimate USD 85 million. * Q4 adjusted EBITDA USD 21 million
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million